|
MACF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.218600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.465000E-03 |
| Normal-vs-Stage2 |
2.024900E-03 |
| Normal-vs-Stage3 |
2.588000E-04 |
| Normal-vs-Stage4 |
2.000500E-04 |
| Stage1-vs-Stage2 |
8.771800E-02 |
| Stage1-vs-Stage3 |
2.751800E-02 |
| Stage1-vs-Stage4 |
2.244000E-02 |
| Stage2-vs-Stage3 |
9.114800E-01 |
| Stage2-vs-Stage4 |
8.455200E-01 |
| Stage3-vs-Stage4 |
7.031800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.209700E-04 |
| Normal-vs-AfricanAmerican |
2.693600E-01 |
| Normal-vs-Asian |
3.965400E-01 |
| Caucasian-vs-AfricanAmerican |
2.410200E-02 |
| Caucasian-vs-Asian |
6.215200E-01 |
| AfricanAmerican-vs-Asian |
7.223400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.816190E-04 |
| Normal-vs-Female |
2.597900E-02 |
| Male-vs-Female |
9.357600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.437200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.959300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.786880E-04 |
| Normal-vs-Age(81-100Yrs) |
4.027100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.155800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.389030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.870460E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.959780E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.344300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.087800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.778560E-01 |
| Normal-vs-Grade 2 |
2.560300E-02 |
| Normal-vs-Grade 3 |
1.60744999999629E-05 |
| Normal-vs-Grade 4 |
6.33110000000103E-05 |
| Grade 1-vs-Grade 2 |
6.437700E-03 |
| Grade 1-vs-Grade 3 |
2.74829999979964E-07 |
| Grade 1-vs-Grade 4 |
3.81299999999696E-05 |
| Grade 2-vs-Grade 3 |
3.66240000000406E-05 |
| Grade 2-vs-Grade 4 |
3.436800E-03 |
| Grade 3-vs-Grade 4 |
8.265400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.479900E-03 |
| Normal-vs-ccB subtype |
4.638400E-04 |
| ccA subtype-vs-ccB subtype |
4.399400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.402000E-04 |
| Normal-vs-N1 |
1.712570E-01 |
| N0-vs-N1 |
7.985800E-01 |
|
|
